Literature DB >> 15723946

Submandibular gland transfer for prevention of xerostomia after radiation therapy: swallowing outcomes.

Jana Rieger1, Hadi Seikaly, Naresh Jha, Jeffrey Harris, David Williams, Richard Liu, Tim McGaw, John Wolfaardt.   

Abstract

OBJECTIVE: To assess swallowing outcomes in patients with oropharyngeal carcinoma in relation to the Seikaly-Jha procedure for submandibular gland transfer (SJP). The SJP has recently been described as beneficial in the prevention of xerostomia induced by radiation therapy in patients with head and neck cancer.
DESIGN: Inception cohort.
SETTING: University-affiliated primary care center. PATIENTS: A phase 2 clinical trial was conducted from February 1, 1999, through February 28, 2002, to evaluate SJP in patients with head and neck cancer. During that period, a consecutive sample of 51 patients who underwent surgical resection and reconstruction with a radial forearm free flap for oropharyngeal carcinoma were referred for functional assessment of swallowing after completion of adjuvant radiation therapy. At 6 months after surgery, swallowing assessments for 24 patients were available. INTERVENTION: The cohort of 24 patients included 13 who had preservation of 1 submandibular gland (SJP group) and 11 who did not (control group). MAIN OUTCOME MEASURES: Quantitative and qualitative aspects of swallowing were obtained to determine whether patients in the SJP group performed more optimally than those in the control group.
RESULTS: Baseline and stimulated salivary flow rates were significantly different between groups. Patients in the SJP group were able to move the bolus through the oral cavity and into the pharynx faster than those in the control group. In addition, patients in the SJP group swallowed less often per bolus than patients in the control group. The complete swallowing sequence was twice as long in controls.
CONCLUSIONS: The SJP for submandibular gland transfer appears to be beneficial in promoting more time-efficient swallowing behaviors. This efficiency has implications for the overall well-being and nutritional status of patients with head and neck cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15723946     DOI: 10.1001/archotol.131.2.140

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

Review 1.  [Cell-based strategies for salivary gland regeneration].

Authors:  N Rotter; C Wirz; J Oder; B Wollenberg; R Huss; S Brandau; S Lang; M Bücheler
Journal:  HNO       Date:  2008-03       Impact factor: 1.284

2.  Comparison of acute toxicities in two primary chemoradiation regimens in the treatment of advanced head and neck squamous cell carcinoma.

Authors:  Katherine Y Fan; Hrishikesh Gogineni; David Zaboli; Spencer Lake; Marianna L Zahurak; Simon R Best; Marshall A Levine; Mei Tang; Eva S Zinreich; John R Saunders; Joseph A Califano; Ray G Blanco; Sara I Pai; Barbara Messing; Patrick K Ha
Journal:  Ann Surg Oncol       Date:  2012-06       Impact factor: 5.344

Review 3.  Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy.

Authors:  Laura S Sasportas; Drew N Hosford; Maria A Sodini; Dale J Waters; Elizabeth A Zambricki; Joëlle K Barral; Edward E Graves; Todd J Brinton; Paul G Yock; Quynh-Thu Le; Davud Sirjani
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-05-03

4.  Free thyroid transfer: Short-term results of a novel procedure to prevent post-radiation hypothyroidism.

Authors:  Jeffrey Harris; Brittany Barber; Hani Almarzouki; Rufus Scrimger; Jacques Romney; Daniel O'Connell; Mark Urken; Hadi Seikaly
Journal:  Head Neck       Date:  2016-11-15       Impact factor: 3.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.